nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Paclitaxel—ovarian cancer	0.167	0.266	CbGbCtD
Sildenafil—ABCC10—Docetaxel—ovarian cancer	0.121	0.193	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—ovarian cancer	0.09	0.144	CbGbCtD
Sildenafil—PDE5A—clitoris—ovarian cancer	0.0341	0.396	CbGeAlD
Sildenafil—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0319	0.0508	CbGbCtD
Sildenafil—CYP3A7—Paclitaxel—ovarian cancer	0.0319	0.0508	CbGbCtD
Sildenafil—CYP3A5—Paclitaxel—ovarian cancer	0.0239	0.0381	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.023	0.0368	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—ovarian cancer	0.023	0.0368	CbGbCtD
Sildenafil—CYP2D6—Vinorelbine—ovarian cancer	0.0209	0.0333	CbGbCtD
Sildenafil—CYP3A4—Topotecan—ovarian cancer	0.0188	0.03	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—ovarian cancer	0.0173	0.0276	CbGbCtD
Sildenafil—CYP2C9—Paclitaxel—ovarian cancer	0.016	0.0256	CbGbCtD
Sildenafil—CYP3A4—Vinorelbine—ovarian cancer	0.0133	0.0212	CbGbCtD
Sildenafil—CYP3A4—Paclitaxel—ovarian cancer	0.00932	0.0149	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—ovarian cancer	0.0079	0.0126	CbGbCtD
Sildenafil—CYP3A4—Docetaxel—ovarian cancer	0.00674	0.0108	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—ovarian cancer	0.00503	0.00802	CbGbCtD
Sildenafil—PDE6G—testis—ovarian cancer	0.00257	0.0299	CbGeAlD
Sildenafil—PDE6G—lymph node—ovarian cancer	0.00187	0.0217	CbGeAlD
Sildenafil—PDE5A—epithelium—ovarian cancer	0.0017	0.0197	CbGeAlD
Sildenafil—PDE5A—uterine cervix—ovarian cancer	0.00168	0.0195	CbGeAlD
Sildenafil—ABCC10—myometrium—ovarian cancer	0.00165	0.0192	CbGeAlD
Sildenafil—ADORA2A—gonad—ovarian cancer	0.00155	0.018	CbGeAlD
Sildenafil—ABCC5—uterine cervix—ovarian cancer	0.00154	0.0179	CbGeAlD
Sildenafil—ABCC5—decidua—ovarian cancer	0.00147	0.017	CbGeAlD
Sildenafil—PDE5A—gonad—ovarian cancer	0.00141	0.0164	CbGeAlD
Sildenafil—ADORA2A—female reproductive system—ovarian cancer	0.00138	0.0161	CbGeAlD
Sildenafil—ABCC10—uterine cervix—ovarian cancer	0.00129	0.0149	CbGeAlD
Sildenafil—PDE5A—female reproductive system—ovarian cancer	0.00126	0.0146	CbGeAlD
Sildenafil—ABCC10—decidua—ovarian cancer	0.00122	0.0142	CbGeAlD
Sildenafil—ABCC10—endometrium—ovarian cancer	0.00116	0.0135	CbGeAlD
Sildenafil—PDE5A—female gonad—ovarian cancer	0.00115	0.0133	CbGeAlD
Sildenafil—PDE5A—vagina—ovarian cancer	0.00114	0.0132	CbGeAlD
Sildenafil—ADORA2A—testis—ovarian cancer	0.00112	0.013	CbGeAlD
Sildenafil—ABCC5—bone marrow—ovarian cancer	0.00109	0.0126	CbGeAlD
Sildenafil—ABCC10—gonad—ovarian cancer	0.00108	0.0125	CbGeAlD
Sildenafil—ABCC10—uterus—ovarian cancer	0.00107	0.0124	CbGeAlD
Sildenafil—ABCC5—female gonad—ovarian cancer	0.00105	0.0122	CbGeAlD
Sildenafil—ABCC5—vagina—ovarian cancer	0.00104	0.0121	CbGeAlD
Sildenafil—PDE5A—testis—ovarian cancer	0.00102	0.0118	CbGeAlD
Sildenafil—ABCC10—female reproductive system—ovarian cancer	0.000963	0.0112	CbGeAlD
Sildenafil—ABCC5—testis—ovarian cancer	0.00093	0.0108	CbGeAlD
Sildenafil—ABCC10—bone marrow—ovarian cancer	0.000909	0.0106	CbGeAlD
Sildenafil—ABCC4—uterus—ovarian cancer	0.000889	0.0103	CbGeAlD
Sildenafil—ABCC10—female gonad—ovarian cancer	0.000876	0.0102	CbGeAlD
Sildenafil—ABCC10—vagina—ovarian cancer	0.000871	0.0101	CbGeAlD
Sildenafil—ABCC4—female reproductive system—ovarian cancer	0.000799	0.00928	CbGeAlD
Sildenafil—ABCC10—testis—ovarian cancer	0.000777	0.00902	CbGeAlD
Sildenafil—ABCC4—bone marrow—ovarian cancer	0.000754	0.00876	CbGeAlD
Sildenafil—PDE5A—lymph node—ovarian cancer	0.000737	0.00856	CbGeAlD
Sildenafil—ABCC4—female gonad—ovarian cancer	0.000727	0.00844	CbGeAlD
Sildenafil—CYP1A1—epithelium—ovarian cancer	0.000721	0.00837	CbGeAlD
Sildenafil—CYP1A1—uterine cervix—ovarian cancer	0.000715	0.0083	CbGeAlD
Sildenafil—CYP3A5—uterine cervix—ovarian cancer	0.000699	0.00811	CbGeAlD
Sildenafil—ABCC5—lymph node—ovarian cancer	0.000674	0.00783	CbGeAlD
Sildenafil—ABCC4—testis—ovarian cancer	0.000645	0.00749	CbGeAlD
Sildenafil—CYP2C19—vagina—ovarian cancer	0.000601	0.00698	CbGeAlD
Sildenafil—CYP1A1—uterus—ovarian cancer	0.000596	0.00691	CbGeAlD
Sildenafil—ABCC10—lymph node—ovarian cancer	0.000563	0.00654	CbGeAlD
Sildenafil—CYP1A1—female reproductive system—ovarian cancer	0.000535	0.00622	CbGeAlD
Sildenafil—CYP2C9—female reproductive system—ovarian cancer	0.000515	0.00598	CbGeAlD
Sildenafil—CYP2E1—female reproductive system—ovarian cancer	0.000488	0.00567	CbGeAlD
Sildenafil—CYP1A1—female gonad—ovarian cancer	0.000487	0.00566	CbGeAlD
Sildenafil—CYP1A1—vagina—ovarian cancer	0.000484	0.00562	CbGeAlD
Sildenafil—CYP3A5—female gonad—ovarian cancer	0.000476	0.00553	CbGeAlD
Sildenafil—CYP3A5—vagina—ovarian cancer	0.000473	0.0055	CbGeAlD
Sildenafil—ABCC4—lymph node—ovarian cancer	0.000467	0.00543	CbGeAlD
Sildenafil—CYP2E1—testis—ovarian cancer	0.000394	0.00457	CbGeAlD
Sildenafil—CYP3A4—female reproductive system—ovarian cancer	0.000393	0.00456	CbGeAlD
Sildenafil—CYP2D6—female reproductive system—ovarian cancer	0.000387	0.00449	CbGeAlD
Sildenafil—CYP2D6—female gonad—ovarian cancer	0.000352	0.00408	CbGeAlD
Sildenafil—CYP1A1—lymph node—ovarian cancer	0.000313	0.00364	CbGeAlD
Sildenafil—CYP2D6—testis—ovarian cancer	0.000312	0.00362	CbGeAlD
Sildenafil—Nausea—Vinorelbine—ovarian cancer	0.000116	0.00047	CcSEcCtD
Sildenafil—Renal failure—Epirubicin—ovarian cancer	0.000116	0.000469	CcSEcCtD
Sildenafil—Dyspepsia—Paclitaxel—ovarian cancer	0.000116	0.000469	CcSEcCtD
Sildenafil—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000115	0.000468	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000115	0.000467	CcSEcCtD
Sildenafil—Stomatitis—Epirubicin—ovarian cancer	0.000115	0.000465	CcSEcCtD
Sildenafil—Urinary tract infection—Epirubicin—ovarian cancer	0.000114	0.000464	CcSEcCtD
Sildenafil—Conjunctivitis—Epirubicin—ovarian cancer	0.000114	0.000464	CcSEcCtD
Sildenafil—Decreased appetite—Paclitaxel—ovarian cancer	0.000114	0.000463	CcSEcCtD
Sildenafil—Dry mouth—Docetaxel—ovarian cancer	0.000114	0.00046	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000114	0.00046	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000113	0.00046	CcSEcCtD
Sildenafil—Fatigue—Paclitaxel—ovarian cancer	0.000113	0.000459	CcSEcCtD
Sildenafil—Sweating—Epirubicin—ovarian cancer	0.000113	0.000457	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—ovarian cancer	0.000113	0.000457	CcSEcCtD
Sildenafil—Pain—Paclitaxel—ovarian cancer	0.000112	0.000455	CcSEcCtD
Sildenafil—Constipation—Paclitaxel—ovarian cancer	0.000112	0.000455	CcSEcCtD
Sildenafil—Haematuria—Epirubicin—ovarian cancer	0.000112	0.000455	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000112	0.000452	CcSEcCtD
Sildenafil—Oedema—Docetaxel—ovarian cancer	0.000111	0.000451	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—ovarian cancer	0.000111	0.000451	CcSEcCtD
Sildenafil—Epistaxis—Epirubicin—ovarian cancer	0.000111	0.00045	CcSEcCtD
Sildenafil—Infection—Docetaxel—ovarian cancer	0.000111	0.000448	CcSEcCtD
Sildenafil—Sinusitis—Epirubicin—ovarian cancer	0.00011	0.000448	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00011	0.000447	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—ovarian cancer	0.00011	0.000444	CcSEcCtD
Sildenafil—Shock—Docetaxel—ovarian cancer	0.00011	0.000444	CcSEcCtD
Sildenafil—Nervous system disorder—Docetaxel—ovarian cancer	0.000109	0.000442	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—ovarian cancer	0.000109	0.000441	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—ovarian cancer	0.000109	0.000441	CcSEcCtD
Sildenafil—Tachycardia—Docetaxel—ovarian cancer	0.000109	0.00044	CcSEcCtD
Sildenafil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000108	0.000439	CcSEcCtD
Sildenafil—Skin disorder—Docetaxel—ovarian cancer	0.000108	0.000438	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000108	0.000438	CcSEcCtD
Sildenafil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000107	0.000435	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—ovarian cancer	0.000107	0.000434	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000107	0.000433	CcSEcCtD
Sildenafil—Haemoglobin—Epirubicin—ovarian cancer	0.000106	0.00043	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—ovarian cancer	0.000106	0.00043	CcSEcCtD
Sildenafil—Anorexia—Docetaxel—ovarian cancer	0.000106	0.00043	CcSEcCtD
Sildenafil—Rhinitis—Epirubicin—ovarian cancer	0.000106	0.000429	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—ovarian cancer	0.000106	0.000429	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—ovarian cancer	0.000106	0.000429	CcSEcCtD
Sildenafil—Haemorrhage—Epirubicin—ovarian cancer	0.000106	0.000428	CcSEcCtD
Sildenafil—Hypoaesthesia—Epirubicin—ovarian cancer	0.000105	0.000426	CcSEcCtD
Sildenafil—Pharyngitis—Epirubicin—ovarian cancer	0.000105	0.000425	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—ovarian cancer	0.000104	0.000423	CcSEcCtD
Sildenafil—Urinary tract disorder—Epirubicin—ovarian cancer	0.000104	0.000423	CcSEcCtD
Sildenafil—Urticaria—Paclitaxel—ovarian cancer	0.000104	0.000423	CcSEcCtD
Sildenafil—Oedema peripheral—Epirubicin—ovarian cancer	0.000104	0.000422	CcSEcCtD
Sildenafil—Hypotension—Docetaxel—ovarian cancer	0.000104	0.000422	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—ovarian cancer	0.000104	0.000421	CcSEcCtD
Sildenafil—Connective tissue disorder—Epirubicin—ovarian cancer	0.000104	0.000421	CcSEcCtD
Sildenafil—Body temperature increased—Paclitaxel—ovarian cancer	0.000104	0.000421	CcSEcCtD
Sildenafil—Abdominal pain—Paclitaxel—ovarian cancer	0.000104	0.000421	CcSEcCtD
Sildenafil—Urethral disorder—Epirubicin—ovarian cancer	0.000104	0.00042	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—ovarian cancer	0.000103	0.000416	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—ovarian cancer	0.000102	0.000414	CcSEcCtD
Sildenafil—Visual impairment—Epirubicin—ovarian cancer	0.000102	0.000413	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000101	0.000411	CcSEcCtD
Sildenafil—Insomnia—Docetaxel—ovarian cancer	0.000101	0.000408	CcSEcCtD
Sildenafil—Paraesthesia—Docetaxel—ovarian cancer	0.0001	0.000405	CcSEcCtD
Sildenafil—Erythema multiforme—Epirubicin—ovarian cancer	9.99e-05	0.000405	CcSEcCtD
Sildenafil—Dyspnoea—Docetaxel—ovarian cancer	9.92e-05	0.000402	CcSEcCtD
Sildenafil—Somnolence—Docetaxel—ovarian cancer	9.9e-05	0.000401	CcSEcCtD
Sildenafil—Eye disorder—Epirubicin—ovarian cancer	9.88e-05	0.0004	CcSEcCtD
Sildenafil—Tinnitus—Epirubicin—ovarian cancer	9.85e-05	0.000399	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—ovarian cancer	9.83e-05	0.000398	CcSEcCtD
Sildenafil—Flushing—Epirubicin—ovarian cancer	9.81e-05	0.000398	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—ovarian cancer	9.81e-05	0.000398	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—ovarian cancer	9.8e-05	0.000397	CcSEcCtD
Sildenafil—Dyspepsia—Docetaxel—ovarian cancer	9.8e-05	0.000397	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—ovarian cancer	9.78e-05	0.000396	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—ovarian cancer	9.73e-05	0.000394	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—ovarian cancer	9.71e-05	0.000393	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—ovarian cancer	9.68e-05	0.000392	CcSEcCtD
Sildenafil—Hypersensitivity—Paclitaxel—ovarian cancer	9.68e-05	0.000392	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—ovarian cancer	9.66e-05	0.000391	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—ovarian cancer	9.63e-05	0.00039	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.61e-05	0.00039	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—ovarian cancer	9.61e-05	0.000389	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—ovarian cancer	9.6e-05	0.000389	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—ovarian cancer	9.59e-05	0.000389	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—ovarian cancer	9.59e-05	0.000388	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—ovarian cancer	9.55e-05	0.000387	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—ovarian cancer	9.52e-05	0.000386	CcSEcCtD
Sildenafil—Pain—Docetaxel—ovarian cancer	9.52e-05	0.000386	CcSEcCtD
Sildenafil—Constipation—Docetaxel—ovarian cancer	9.52e-05	0.000386	CcSEcCtD
Sildenafil—Chills—Epirubicin—ovarian cancer	9.48e-05	0.000384	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—ovarian cancer	9.44e-05	0.000383	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—ovarian cancer	9.42e-05	0.000382	CcSEcCtD
Sildenafil—Asthenia—Paclitaxel—ovarian cancer	9.42e-05	0.000382	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—ovarian cancer	9.34e-05	0.000378	CcSEcCtD
Sildenafil—Pruritus—Paclitaxel—ovarian cancer	9.29e-05	0.000377	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—ovarian cancer	9.26e-05	0.000375	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—ovarian cancer	9.25e-05	0.000375	CcSEcCtD
Sildenafil—Erythema—Epirubicin—ovarian cancer	9.2e-05	0.000373	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—ovarian cancer	9.2e-05	0.000373	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—ovarian cancer	9.17e-05	0.000372	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—ovarian cancer	9.14e-05	0.00037	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—ovarian cancer	9.12e-05	0.00037	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—ovarian cancer	9.1e-05	0.000369	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—ovarian cancer	9.08e-05	0.000368	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—ovarian cancer	9.08e-05	0.000368	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—ovarian cancer	9.07e-05	0.000367	CcSEcCtD
Sildenafil—Tension—Epirubicin—ovarian cancer	9.03e-05	0.000366	CcSEcCtD
Sildenafil—Diarrhoea—Paclitaxel—ovarian cancer	8.99e-05	0.000364	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—ovarian cancer	8.94e-05	0.000362	CcSEcCtD
Sildenafil—Back pain—Epirubicin—ovarian cancer	8.9e-05	0.000361	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—ovarian cancer	8.87e-05	0.00036	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—ovarian cancer	8.83e-05	0.000358	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—ovarian cancer	8.81e-05	0.000357	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—ovarian cancer	8.8e-05	0.000357	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—ovarian cancer	8.8e-05	0.000357	CcSEcCtD
Sildenafil—Chills—Doxorubicin—ovarian cancer	8.77e-05	0.000356	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—ovarian cancer	8.74e-05	0.000354	CcSEcCtD
Sildenafil—Dizziness—Paclitaxel—ovarian cancer	8.68e-05	0.000352	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—ovarian cancer	8.67e-05	0.000351	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—ovarian cancer	8.64e-05	0.00035	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—ovarian cancer	8.57e-05	0.000347	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—ovarian cancer	8.54e-05	0.000346	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—ovarian cancer	8.51e-05	0.000345	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—ovarian cancer	8.51e-05	0.000345	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—ovarian cancer	8.5e-05	0.000345	CcSEcCtD
Sildenafil—Agitation—Epirubicin—ovarian cancer	8.45e-05	0.000343	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—ovarian cancer	8.39e-05	0.00034	CcSEcCtD
Sildenafil—Tension—Doxorubicin—ovarian cancer	8.35e-05	0.000339	CcSEcCtD
Sildenafil—Vomiting—Paclitaxel—ovarian cancer	8.35e-05	0.000338	CcSEcCtD
Sildenafil—Malaise—Epirubicin—ovarian cancer	8.3e-05	0.000336	CcSEcCtD
Sildenafil—Rash—Paclitaxel—ovarian cancer	8.28e-05	0.000336	CcSEcCtD
Sildenafil—Dermatitis—Paclitaxel—ovarian cancer	8.27e-05	0.000335	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—ovarian cancer	8.27e-05	0.000335	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—ovarian cancer	8.27e-05	0.000335	CcSEcCtD
Sildenafil—Syncope—Epirubicin—ovarian cancer	8.25e-05	0.000334	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—ovarian cancer	8.23e-05	0.000334	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—ovarian cancer	8.23e-05	0.000334	CcSEcCtD
Sildenafil—Headache—Paclitaxel—ovarian cancer	8.23e-05	0.000333	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—ovarian cancer	8.2e-05	0.000332	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—ovarian cancer	8.13e-05	0.00033	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—ovarian cancer	8.09e-05	0.000328	CcSEcCtD
Sildenafil—Cough—Epirubicin—ovarian cancer	8.03e-05	0.000325	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—ovarian cancer	8.02e-05	0.000325	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—ovarian cancer	7.99e-05	0.000324	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—ovarian cancer	7.97e-05	0.000323	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—ovarian cancer	7.94e-05	0.000322	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—ovarian cancer	7.9e-05	0.00032	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—ovarian cancer	7.88e-05	0.000319	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—ovarian cancer	7.87e-05	0.000319	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—ovarian cancer	7.83e-05	0.000317	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—ovarian cancer	7.83e-05	0.000317	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—ovarian cancer	7.83e-05	0.000317	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—ovarian cancer	7.82e-05	0.000317	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—ovarian cancer	7.81e-05	0.000316	CcSEcCtD
Sildenafil—Nausea—Paclitaxel—ovarian cancer	7.8e-05	0.000316	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.78e-05	0.000315	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—ovarian cancer	7.74e-05	0.000314	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—ovarian cancer	7.68e-05	0.000311	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—ovarian cancer	7.66e-05	0.00031	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—ovarian cancer	7.65e-05	0.00031	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—ovarian cancer	7.63e-05	0.000309	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—ovarian cancer	7.62e-05	0.000309	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—ovarian cancer	7.62e-05	0.000309	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—ovarian cancer	7.52e-05	0.000305	CcSEcCtD
Sildenafil—Oedema—Epirubicin—ovarian cancer	7.51e-05	0.000304	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—ovarian cancer	7.48e-05	0.000303	CcSEcCtD
Sildenafil—Infection—Epirubicin—ovarian cancer	7.46e-05	0.000302	CcSEcCtD
Sildenafil—Cough—Doxorubicin—ovarian cancer	7.43e-05	0.000301	CcSEcCtD
Sildenafil—Shock—Epirubicin—ovarian cancer	7.39e-05	0.000299	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—ovarian cancer	7.38e-05	0.000299	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—ovarian cancer	7.36e-05	0.000298	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—ovarian cancer	7.36e-05	0.000298	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—ovarian cancer	7.35e-05	0.000298	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—ovarian cancer	7.33e-05	0.000297	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—ovarian cancer	7.29e-05	0.000296	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—ovarian cancer	7.26e-05	0.000294	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—ovarian cancer	7.25e-05	0.000294	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—ovarian cancer	7.25e-05	0.000294	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—ovarian cancer	7.25e-05	0.000294	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—ovarian cancer	7.22e-05	0.000293	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	7.2e-05	0.000292	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—ovarian cancer	7.16e-05	0.00029	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—ovarian cancer	7.16e-05	0.00029	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—ovarian cancer	7.09e-05	0.000287	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—ovarian cancer	7.08e-05	0.000287	CcSEcCtD
Sildenafil—Rash—Docetaxel—ovarian cancer	7.02e-05	0.000284	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—ovarian cancer	7.02e-05	0.000284	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—ovarian cancer	7.01e-05	0.000284	CcSEcCtD
Sildenafil—Headache—Docetaxel—ovarian cancer	6.97e-05	0.000283	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—ovarian cancer	6.95e-05	0.000282	CcSEcCtD
Sildenafil—Infection—Doxorubicin—ovarian cancer	6.9e-05	0.00028	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.84e-05	0.000277	CcSEcCtD
Sildenafil—Shock—Doxorubicin—ovarian cancer	6.84e-05	0.000277	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—ovarian cancer	6.81e-05	0.000276	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—ovarian cancer	6.79e-05	0.000275	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—ovarian cancer	6.78e-05	0.000275	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—ovarian cancer	6.75e-05	0.000273	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—ovarian cancer	6.74e-05	0.000273	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—ovarian cancer	6.72e-05	0.000272	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—ovarian cancer	6.69e-05	0.000271	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—ovarian cancer	6.67e-05	0.000271	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—ovarian cancer	6.62e-05	0.000268	CcSEcCtD
Sildenafil—Nausea—Docetaxel—ovarian cancer	6.61e-05	0.000268	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—ovarian cancer	6.61e-05	0.000268	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—ovarian cancer	6.53e-05	0.000265	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—ovarian cancer	6.49e-05	0.000263	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.48e-05	0.000263	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—ovarian cancer	6.47e-05	0.000262	CcSEcCtD
Sildenafil—Pain—Epirubicin—ovarian cancer	6.42e-05	0.00026	CcSEcCtD
Sildenafil—Constipation—Epirubicin—ovarian cancer	6.42e-05	0.00026	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.33e-05	0.000257	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—ovarian cancer	6.28e-05	0.000255	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—ovarian cancer	6.24e-05	0.000253	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—ovarian cancer	6.19e-05	0.000251	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—ovarian cancer	6.19e-05	0.000251	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—ovarian cancer	6.18e-05	0.00025	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—ovarian cancer	6.14e-05	0.000249	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—ovarian cancer	6.12e-05	0.000248	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—ovarian cancer	6.04e-05	0.000245	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6e-05	0.000243	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—ovarian cancer	5.99e-05	0.000243	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—ovarian cancer	5.96e-05	0.000242	CcSEcCtD
Sildenafil—Pain—Doxorubicin—ovarian cancer	5.94e-05	0.000241	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—ovarian cancer	5.94e-05	0.000241	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—ovarian cancer	5.94e-05	0.000241	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—ovarian cancer	5.94e-05	0.000241	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—ovarian cancer	5.72e-05	0.000232	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.68e-05	0.00023	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—ovarian cancer	5.53e-05	0.000224	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—ovarian cancer	5.52e-05	0.000224	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—ovarian cancer	5.49e-05	0.000223	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—ovarian cancer	5.49e-05	0.000223	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—ovarian cancer	5.39e-05	0.000218	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—ovarian cancer	5.31e-05	0.000215	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—ovarian cancer	5.14e-05	0.000208	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—ovarian cancer	5.12e-05	0.000207	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—ovarian cancer	4.98e-05	0.000202	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—ovarian cancer	4.97e-05	0.000201	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—ovarian cancer	4.92e-05	0.000199	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—ovarian cancer	4.77e-05	0.000193	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—ovarian cancer	4.75e-05	0.000193	CcSEcCtD
Sildenafil—Rash—Epirubicin—ovarian cancer	4.73e-05	0.000192	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—ovarian cancer	4.73e-05	0.000192	CcSEcCtD
Sildenafil—Headache—Epirubicin—ovarian cancer	4.7e-05	0.000191	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—ovarian cancer	4.59e-05	0.000186	CcSEcCtD
Sildenafil—Nausea—Epirubicin—ovarian cancer	4.46e-05	0.000181	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—ovarian cancer	4.42e-05	0.000179	CcSEcCtD
Sildenafil—Rash—Doxorubicin—ovarian cancer	4.38e-05	0.000178	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—ovarian cancer	4.38e-05	0.000177	CcSEcCtD
Sildenafil—Headache—Doxorubicin—ovarian cancer	4.35e-05	0.000176	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—ovarian cancer	4.13e-05	0.000167	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—MMP9—ovarian cancer	1.57e-05	0.00039	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTEN—ovarian cancer	1.56e-05	0.000388	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—ovarian cancer	1.55e-05	0.000386	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NME2—ovarian cancer	1.54e-05	0.000384	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NRAS—ovarian cancer	1.53e-05	0.000382	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYTB—ovarian cancer	1.52e-05	0.000379	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CG—ovarian cancer	1.52e-05	0.000378	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYTB—ovarian cancer	1.51e-05	0.000376	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PPP2R1A—ovarian cancer	1.5e-05	0.000373	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CD—ovarian cancer	1.49e-05	0.000372	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.48e-05	0.000367	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK3—ovarian cancer	1.47e-05	0.000366	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—ovarian cancer	1.45e-05	0.000361	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.45e-05	0.00036	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.45e-05	0.00036	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	1.43e-05	0.000357	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—FASN—ovarian cancer	1.42e-05	0.000352	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB2—ovarian cancer	1.41e-05	0.00035	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—ovarian cancer	1.41e-05	0.00035	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK1—ovarian cancer	1.4e-05	0.000348	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—STAT3—ovarian cancer	1.39e-05	0.000347	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.39e-05	0.000346	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MTOR—ovarian cancer	1.39e-05	0.000346	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CB—ovarian cancer	1.39e-05	0.000346	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NRAS—ovarian cancer	1.39e-05	0.000346	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IL6—ovarian cancer	1.39e-05	0.000346	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCL8—ovarian cancer	1.38e-05	0.000343	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.34e-05	0.000335	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CD—ovarian cancer	1.34e-05	0.000332	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.33e-05	0.000331	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.33e-05	0.000331	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK3—ovarian cancer	1.33e-05	0.000331	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—ovarian cancer	1.32e-05	0.000329	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.32e-05	0.000328	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.32e-05	0.000328	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2—ovarian cancer	1.32e-05	0.000328	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1B—ovarian cancer	1.3e-05	0.000325	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CB—ovarian cancer	1.3e-05	0.000324	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—ovarian cancer	1.29e-05	0.000322	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.29e-05	0.000321	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.29e-05	0.000321	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—ovarian cancer	1.28e-05	0.000319	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK1—ovarian cancer	1.27e-05	0.000315	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—ovarian cancer	1.27e-05	0.000315	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—YAP1—ovarian cancer	1.26e-05	0.000313	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—YAP1—ovarian cancer	1.26e-05	0.000312	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL8—ovarian cancer	1.25e-05	0.000311	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—ovarian cancer	1.23e-05	0.000307	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—ovarian cancer	1.21e-05	0.000302	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—ovarian cancer	1.2e-05	0.000299	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2—ovarian cancer	1.2e-05	0.000298	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—ovarian cancer	1.2e-05	0.000298	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TERT—ovarian cancer	1.19e-05	0.000297	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—YAP1—ovarian cancer	1.19e-05	0.000295	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.17e-05	0.000292	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—ovarian cancer	1.17e-05	0.000292	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CB—ovarian cancer	1.16e-05	0.00029	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.14e-05	0.000285	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—ovarian cancer	1.12e-05	0.000279	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CAV1—ovarian cancer	1.1e-05	0.000274	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—ovarian cancer	1.1e-05	0.000273	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—ovarian cancer	1.07e-05	0.000267	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NRAS—ovarian cancer	1.07e-05	0.000267	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—ovarian cancer	1.06e-05	0.000264	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ESR1—ovarian cancer	1.06e-05	0.000264	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.06e-05	0.000264	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.05e-05	0.000262	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6ST—ovarian cancer	1.05e-05	0.00026	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TYMS—ovarian cancer	1.04e-05	0.000259	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.03e-05	0.000257	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK3—ovarian cancer	1.03e-05	0.000255	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—FASN—ovarian cancer	1.03e-05	0.000255	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—FASN—ovarian cancer	1.02e-05	0.000255	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—ovarian cancer	1.02e-05	0.000253	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.01e-05	0.000251	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.01e-05	0.00025	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—ovarian cancer	1.01e-05	0.00025	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—ovarian cancer	1e-05	0.00025	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—ovarian cancer	1e-05	0.00025	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—NRAS—ovarian cancer	1e-05	0.00025	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—ovarian cancer	9.98e-06	0.000248	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYTB—ovarian cancer	9.96e-06	0.000248	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—ovarian cancer	9.91e-06	0.000247	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK1—ovarian cancer	9.77e-06	0.000243	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—ovarian cancer	9.76e-06	0.000243	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC2A1—ovarian cancer	9.74e-06	0.000242	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—ovarian cancer	9.73e-06	0.000242	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC2A1—ovarian cancer	9.72e-06	0.000242	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—YAP1—ovarian cancer	9.71e-06	0.000241	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—FASN—ovarian cancer	9.67e-06	0.000241	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK3—ovarian cancer	9.62e-06	0.000239	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.62e-06	0.000239	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.61e-06	0.000239	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC5A5—ovarian cancer	9.51e-06	0.000237	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1B1—ovarian cancer	9.34e-06	0.000232	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1B1—ovarian cancer	9.32e-06	0.000232	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—ovarian cancer	9.22e-06	0.000229	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC2A1—ovarian cancer	9.19e-06	0.000229	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK1—ovarian cancer	9.15e-06	0.000228	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—ovarian cancer	9.15e-06	0.000228	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.99e-06	0.000224	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—ovarian cancer	8.98e-06	0.000223	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—YAP1—ovarian cancer	8.93e-06	0.000222	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—YAP1—ovarian cancer	8.85e-06	0.00022	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CD—ovarian cancer	8.83e-06	0.00022	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP1B1—ovarian cancer	8.81e-06	0.000219	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.76e-06	0.000218	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	8.74e-06	0.000218	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BRIP1—ovarian cancer	8.7e-06	0.000217	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	8.7e-06	0.000217	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—ovarian cancer	8.64e-06	0.000215	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—ovarian cancer	8.47e-06	0.000211	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.44e-06	0.00021	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CAV1—ovarian cancer	8.4e-06	0.000209	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	8.28e-06	0.000206	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	8.27e-06	0.000206	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—ovarian cancer	7.94e-06	0.000198	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—FASN—ovarian cancer	7.91e-06	0.000197	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—ovarian cancer	7.84e-06	0.000195	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	7.81e-06	0.000194	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—ovarian cancer	7.8e-06	0.000194	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC5A5—ovarian cancer	7.78e-06	0.000194	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.77e-06	0.000193	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.7e-06	0.000192	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CB—ovarian cancer	7.69e-06	0.000191	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MTOR—ovarian cancer	7.69e-06	0.000191	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—ovarian cancer	7.69e-06	0.000191	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—ovarian cancer	7.68e-06	0.000191	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—ovarian cancer	7.65e-06	0.00019	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TYMS—ovarian cancer	7.55e-06	0.000188	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TYMS—ovarian cancer	7.54e-06	0.000188	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC2A1—ovarian cancer	7.52e-06	0.000187	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—ovarian cancer	7.5e-06	0.000187	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—ovarian cancer	7.39e-06	0.000184	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.36e-06	0.000183	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—ovarian cancer	7.35e-06	0.000183	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—FASN—ovarian cancer	7.28e-06	0.000181	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—ovarian cancer	7.25e-06	0.00018	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—ovarian cancer	7.22e-06	0.00018	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—FASN—ovarian cancer	7.21e-06	0.000179	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1B1—ovarian cancer	7.21e-06	0.000179	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A5—ovarian cancer	7.16e-06	0.000178	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—ovarian cancer	7.14e-06	0.000178	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—ovarian cancer	7.12e-06	0.000177	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—ovarian cancer	7.1e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	7.1e-06	0.000177	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—ovarian cancer	7.08e-06	0.000176	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—ovarian cancer	7.07e-06	0.000176	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—ovarian cancer	7.03e-06	0.000175	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—ovarian cancer	6.92e-06	0.000172	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC2A1—ovarian cancer	6.91e-06	0.000172	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—ovarian cancer	6.89e-06	0.000171	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.85e-06	0.000171	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—ovarian cancer	6.82e-06	0.00017	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—ovarian cancer	6.73e-06	0.000167	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.71e-06	0.000167	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—ovarian cancer	6.69e-06	0.000166	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—ovarian cancer	6.65e-06	0.000165	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1B1—ovarian cancer	6.63e-06	0.000165	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	6.57e-06	0.000163	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—ovarian cancer	6.49e-06	0.000161	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	6.39e-06	0.000159	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.36e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAV1—ovarian cancer	6.09e-06	0.000151	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAV1—ovarian cancer	6.07e-06	0.000151	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—ovarian cancer	6.01e-06	0.000149	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—ovarian cancer	5.95e-06	0.000148	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.93e-06	0.000148	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—ovarian cancer	5.93e-06	0.000148	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.88e-06	0.000146	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—ovarian cancer	5.87e-06	0.000146	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—YAP1—ovarian cancer	5.84e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—ovarian cancer	5.83e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.83e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.8e-06	0.000144	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—ovarian cancer	5.8e-06	0.000144	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAV1—ovarian cancer	5.74e-06	0.000143	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—ovarian cancer	5.68e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—ovarian cancer	5.54e-06	0.000138	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.53e-06	0.000138	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—ovarian cancer	5.53e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.48e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—ovarian cancer	5.46e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.41e-06	0.000135	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK1—ovarian cancer	5.41e-06	0.000134	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—ovarian cancer	5.4e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—ovarian cancer	5.36e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—ovarian cancer	5.31e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—ovarian cancer	5.23e-06	0.00013	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—ovarian cancer	5.11e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—ovarian cancer	5.07e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—ovarian cancer	4.87e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.86e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FASN—ovarian cancer	4.76e-06	0.000118	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAV1—ovarian cancer	4.7e-06	0.000117	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—ovarian cancer	4.69e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.68e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—ovarian cancer	4.6e-06	0.000114	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—ovarian cancer	4.54e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.52e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.49e-06	0.000112	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—ovarian cancer	4.34e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.33e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAV1—ovarian cancer	4.32e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAV1—ovarian cancer	4.28e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.28e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—ovarian cancer	4.25e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.24e-06	0.000105	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—ovarian cancer	4.15e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.09e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—ovarian cancer	4.01e-06	9.97e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.93e-06	9.79e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.9e-06	9.7e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.84e-06	9.56e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—ovarian cancer	3.83e-06	9.53e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.76e-06	9.36e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—ovarian cancer	3.67e-06	9.13e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—ovarian cancer	3.66e-06	9.11e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.58e-06	8.9e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.57e-06	8.88e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—ovarian cancer	3.5e-06	8.72e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—ovarian cancer	3.46e-06	8.61e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.46e-06	8.61e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.43e-06	8.53e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.28e-06	8.16e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—ovarian cancer	3.01e-06	7.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.99e-06	7.44e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—ovarian cancer	2.92e-06	7.27e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—ovarian cancer	2.83e-06	7.05e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAV1—ovarian cancer	2.82e-06	7.03e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—ovarian cancer	2.61e-06	6.48e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.59e-06	6.44e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.58e-06	6.43e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—ovarian cancer	2.58e-06	6.43e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.57e-06	6.4e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—ovarian cancer	2.44e-06	6.08e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.26e-06	5.63e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—ovarian cancer	2.12e-06	5.26e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—ovarian cancer	2.11e-06	5.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2e-06	4.97e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—ovarian cancer	1.99e-06	4.96e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.97e-06	4.9e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.84e-06	4.57e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.82e-06	4.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—ovarian cancer	1.7e-06	4.24e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—ovarian cancer	1.63e-06	4.06e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—ovarian cancer	1.5e-06	3.74e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—ovarian cancer	1.49e-06	3.7e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.2e-06	2.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—ovarian cancer	9.82e-07	2.44e-05	CbGpPWpGaD
